Yesterday, for a second time, President Trump said drug companies are getting away with murder. This time Trump talked about how much lower drug prices are in other countries:
“If you look at the same exact drug, by the same exact company…sold someplace else, sometimes it’s a fraction of what we pay in this country…We want to bring our prices down to what other countries are paying. I don’t mean [Americans] are paying 2% more. I mean they are paying double, triple, quadruple…”
Using executive authority under current law to expand access to lower-cost imported medications, President Trump could do something about it immediately. The guy is no stranger to executive authority! Currently, he’s using executive authority to put Obamacare out of business, measures which, in case you were wondering, I strongly oppose. Those moves will make people lose their health insurance and are opposed by over half my fellow Americans.
In contrast, if President Trump used his executive authority on drug prices, he would get an overwhelming chorus of support from the Left, Middle, Right and every which way around.
So how does this go down?
Under current law, the Secretary of the Department of Health and Human Services, an executive branch agency, can “by regulation or on a case-by-case basis…permit individuals” to import medication if “the importation is clearly for personal use…and the prescription drug or device imported does not appear to present an unreasonable risk to the individual.”
What are you waiting for, boss? See the report by Prescription Justice on using executive authority to allow safe personal drug importation from international online pharmacies.
Tagged with: drug industry, Drug Prices, executive authority, executive order, trump
Part D open enrollment for 2018 has begun and will continue through December 7th. During this time, if you’re a Medicare enrollee and do not have a plan, then you should pick one. If you already have a plan, you should shop around because plans change! Premiums and deductibles go up or down, drugs get dropped from formularies, new plans come into the marketplace and others exit. Our website, MedicareDrugPlans.com, has a variety of basic plan information to help you in your search, such as premiums, deductibles, coverage gaps, and whether the plan premium is waived if you have a lower income. The most useful thing about MedicareDrugPlans.com is that you can read ratings and reviews about the plans by people who actually know because they use them. That means that if you were using Part D during 2017, you have the opportunity to help others and rate your plan.
MedicareDrugPlans.com is a supplemental information site to maximize your research when choosing your plan. However, the best place to finalize and select your plan is the on the government’s website. There, you will enter in your zip code, Medicare info, names of the medications you take, and find out which plans cover those medications.
As usual, current plan ratings and reviews don’t paint a pretty picture of Medicare Part D.
PLEASE: I strongly advise, (more…)
Tagged with: government assistance, healthcare, Medicare, medicare plans, Part D, ratings, reviews
The FDA has just announced that the next few weeks may spell shortages of some critical, life-saving medications. Why? Well, a lot of pharmaceuticals you rely on here in the U.S. are manufactured in Puerto Rico, the U.S. territory which was tragically recently hit—and hit hard— by Hurricane Maria. If your medication is not available on U.S. pharmacy shelves, then you may be able to find it online, where it may be stocked internationally, but make sure to stick to pharmacy websites verified by PharmacyChecker.
According to the NY Times, there are 80 plants in PR that make drugs for the U.S., including Xarelto and Humira, accounting for $15 billion in sales last year. The industry states (more…)
Tagged with: hurricane, puerto rico, shortages